Drug giant Novartis’ Sandoz division plans to launch an EpiPen rival in early 2019, marking an end in sight for the 17-month saga that has stretched...
AbbVie revealed on Wednesday that it had halted patient enrollment in a late-stage clinical trial for a small-cell lung cancer drug after poor patient outcomes.Flickr/Ed Uthman...
